Journament

Keyword Connections - pharmacokinetics Keywords

Connection Type	Connection
Journals	Scientific reports Journal of ethnopharmacology Nanoscale Frontiers in pharmacology International journal of pharmaceutics PloS one Molecules (Basel, Switzerland) Journal of chromatographic science aaps pharmscitech ACS omega materials science & engineering c, materials for biological applications nanomedicine (london, england) Transplantation medchemcomm malaria journal journal of chromatography b, analytical technologies in the biomedical and life sciences Journal of pharmaceutical and biomedical analysis Drug and alcohol dependence journal of pharmaceutical sciences Therapeutic drug monitoring British journal of clinical pharmacology biochemical pharmacology american journal of transplantation : official journal of the american society of transplantation and the american society of transplant surgeons Xenobiotica; the fate of foreign compounds in biological systems European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Journal of biomolecular structure & dynamics Future medicinal chemistry Pharmaceutics revista latino-americana de enfermagem clinical gastroenterology and hepatology : the official clinical practice journal of the american gastroenterological association JAMA network open expert opinion on drug discovery pediatric transplantation Animals : an open access journal from MDPI drug development and industrial pharmacy clinical pharmacology and therapeutics Journal of the College of Physicians and Surgeons--Pakistan : JCPSP artificial intelligence in medicine International ophthalmology biotechnology advances american journal of physical medicine & rehabilitation The Review of scientific instruments pharmacy practice journal of the american pharmacists association : japha EMBO reports drug delivery and translational research the journal of political economy expert opinion on pharmacotherapy Journal of inflammation research expert opinion on drug metabolism & toxicology clinical and translational science international journal of antimicrobial agents cancer chemotherapy and pharmacology saudi journal of kidney diseases and transplantation : an official publication of the saudi center for organ transplantation, saudi arabia biology of blood and marrow transplantation : journal of the american society for blood and marrow transplantation Annual Review of Biochemistry biomedical chromatography : bmc the lancet oncology the journal of pharmacology and experimental therapeutics international journal of pharmaceutics: x Chemical & pharmaceutical bulletin cell chemical biology pancreas Naunyn-Schmiedeberg's Archives of Pharmacology scandinavian journal of clinical and laboratory investigation therapie
Research Groups	No Research Group Connected
Bibliographies	[1] Improved bioavailability of Azelnidipine gastro retentive tablets-optimization and in-vivo assessment. [2] Transdermal Adhesive Patches Loaded with Ketoprofen Evaluated by Dynamic Detection of Percutaneous Absorption. [3] evaluation of poloxamer forming gels for bedaquiline fumarate salt and pharmacokinetics following intramuscular injection in rats. [4] The Optimizing Care Model: A novel community pharmacy approach to enhance patient care delivery by leveraging the technician workforce through technician product verification. [5] Biotransformation, Using Recombinant CYP450-Expressing Baker's Yeast Cells, Identifies a Novel CYP2D6.10 Variant Which Is a Superior Metabolizer of Codeine to Morphine Than the Wild-Type Enzyme. [6] Khellinoflavanone, a Semisynthetic Derivative of Khellin, Overcomes Benzo[]pyrene Toxicity in Human Normal and Cancer Cells That Express CYP1A1. [7] High-Performance Membrane Capacitive Deionization Based on Metal-Organic Framework-Derived Hierarchical Carbon Structures. [8] Simultaneous Quantification of Seven Constituents from Zaoren Anshen Prescription and Four Endogenic Components in Rat Plasma by UHPLC-TSQ-MS/MS and the Application of the Correlation Study. [9] Simultaneous determination of calycosin-7-O-β-D-glucoside, cinnamic acid, paeoniflorin and albiflorin in rat plasma by UHPLC-MS/MS and its application to a pharmacokinetic study of Huangqi Guizhi Wuwu Decoction. [10] Simultaneous determination of eight bioactive components in rat plasma after oral administration of Yan-Ke-Ning-Tablet by liquid chromatography coupled with Q-Exactive Orbitrap tandem mass spectrometry. [11] Pharmacokinetics and Tissue Distribution of Gingerols and Shogaols from Ginger ( Rosc.) in Rats by UPLC⁻Q-Exactive⁻HRMS. [12] Simultaneous determination of six bioactive saponins from Rhizoma Panacis Japonici in rat plasma by UHPLC-MS/MS: Application to a pharmacokinetic study. [13] A comparative pharmacokinetic study of three flavonoids and three anthraquinones in normal and gastrointestinal motility disorders rat plasma after the oral administration of Wei-Chang-Shu tablet using high-performance liquid chromatography-tandem mass spectrometry. [14] A UHPLC-MS/MS method for simultaneous determination of twelve constituents from Erigeron breviscapus extract in rat plasma: Application to a pharmacokinetic study. [15] Simultaneous determination of shanzhiside methyl ester, 8-O-acetylshan- zhiside methyl ester and luteolin-7-O-β-D-glucopyranoside in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study after oral administration of Lamiophlomis rotata Pill. [16] Simultaneous determination of seven alkaloids in rat plasma by UFLC-MS/MS and its application to a pharmacokinetic study after oral administration of Cerebralcare Granule. [17] Human error in daily intensive nursing care. [18] Simultaneous determination of six bioactive constituents of Guizhi Fuling Capsule in rat plasma by UHPLC-MS/MS: Application to a pharmacokinetic study. [19] Simultaneous determination of ten compounds in rat plasma by UPLC-MS/MS: Application in the pharmacokinetic study of Ma-Zi-Ren-Wan. [20] Successful recovery from iatrogenic severe hypernatremia and severe metabolic acidosis resulting from accidental use of inappropriate bicarbonate concentrate for hemodialysis treatment. [21] Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase 1 Multiple Ascending Dose Study. [22] Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis. [23] In vivo evaluation of isoprenoid triazole bisphosphonate inhibitors of geranylgeranyl diphosphate synthase: impact of olefin stereochemistry on toxicity and biodistribution. [24] Personalized oncology with artificial intelligence: The case of temozolomide. [25] Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study. [26] Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial. [27] Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors. [28] Relationship between skin melanin index and nicotine pharmacokinetics in African American smokers. [29] Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis. [30] Validation of an UHPLC-MS/MS Method for the Determination of Glaucocalyxin A, a Novel Potent Negative Akt Regulator in Rat Plasma, Lung and Brain Tissues: Application to a Pharmacokinetic Study. [31] A Sensitive and Quantitative Isotope-Dilution LC-MS/MS Method for Analysis of Hydrazine in Tobacco Smoke. [32] Improving the biopharmaceutical attributes of mangiferin using vitamin E-TPGS co-loaded self-assembled phosholipidic nano-mixed micellar systems. [33] Preparation and evaluation of azilsartan osmotic pump tablets based on the preformulation investigation. [34] Pharmacokinetics of tacrolimus granules in pediatric de novo liver, kidney, and heart transplantation: The OPTION study. [35] Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients. [36] Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). [37] Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring. [38] Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling. [39] Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil. [40] Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients. [41] [Level of evidence for therapeutic drug monitoring of everolimus]. [42] Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study. [43] Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus. [44] Determination of total, free and saliva mycophenolic acid with a LC-MS/MS method: application to pharmacokinetic study in healthy volunteers and renal transplant patients. [45] Mycophenolate blood level monitoring: recent progress. [46] LC-ESI-MS/MS assay development and validation of a novel antidiabetic peptide PSTi8 in mice plasma using SPE: An application to pharmacokinetics. [47] Impact of collagen-induced arthritis on the pharmacokinetic disposition of voriconazole, a widely used antifungal agent: in vitro and in vivo investigations in DBA/1J mice. [48] A compartmental approach to isosteviol's disposition in Sprague-Dawley rats. [49] Synthesis and anti-cancer activities of glycosides and glycoconjugates of diterpenoid isosteviol. [50] Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divide. [51] Evaluation of pharmacokinetics and blood-brain barrier permeability of mitragynine using in vivo microdialysis technique. [52] Mechanistic multi-scale pharmacokinetic model for the anticancer drug gemcitabine in pancreatic cancer. [53] Bio-informational futures: The convergence of artificial intelligence and synthetic biology. [54] Higher Optimization of Pharmacokinetic and Pharmacodynamic Parameters Through Loading Dose of Intravenous Colistin in Pediatric Patients. [55] A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA. [56] Evaluating Enhancer Function and Transcription. [57] Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19. [58] Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery. [59] Development of a sensitive and rapid UHPLC-MS/MS method for simultaneous quantification of nine compounds in rat plasma and application in a comparative pharmacokinetic study after oral administration of Xuefu Zhuyu Decoction and nimodipine. [60] The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history. [61] Pharmacokinetics of mefloquine administered with artesunate in patients with uncomplicated falciparum malaria from the Brazilian Amazon basin. [62] Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis. [63] pharmacokinetics and dose response of three different anti-tb drugs in rat (balb/c) infection model of tuberculosis [64] pharmacokinetics of sublingually delivered fentanyl in head and neck cancer patients treated with curatively aimed chemo or bioradiotherapy [65] population pharmacokinetic modeling of a desmopressin oral lyophilisate in growing piglets as a model for the pediatric population [66] npt-iib inhibition does not improve hyperphosphatemia in ckd [67] a multi-scale modeling framework for individualized, spatiotemporal prediction of drug effects and toxicological risk [68] bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers [69] pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (imc‐3g3) to patients with advanced soft tissue sarcoma [70] lc–ms/ms assay for pitavastatin in human plasma and subsequent application to a clinical study in healthy chinese volunteers [71] changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus [72] in vitro and in vivo pharmacology and pharmacokinetics of a human engineered™ monoclonal antibody to epithelial cell adhesion molecule [73] Improved pharmacokinetic characteristics of ursolic acid in rats following intratracheal instillation and nose-only inhalation exposure. [74] Inhibitory Effect of Imperatorin on the Pharmacokinetics of Diazepam In Vitro and In Vivo. [75] nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments [76] determination of captopril by hplctandem mass spectrometry: application in a bioequivalence study [77] possible drug–drug interaction in dogs and cats resulted from alteration in drug metabolism: a mini review [78] Antiviral activity of traditional medicinal plants from Ayurveda against SARS-CoV-2 infection. [79] enhanced uptake of ifosfamide into gh3 prolactinomas with hypercapnic hyperoxic gases monitored in vivo by 31p mrs [80] can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin? [81] a review on central nervous system effects of gastrodin [82] pharmacokinetic studies on oximes in organophosphate poisoning: a mini review [83] pharmacokinetics and dosimetry studies for optimization of pretargeted radioimmunotherapy in cea-expressing advanced lung cancer patients [84] comparative pharmacokinetics of gallic acid after oral administration of gallic acid monohydrate in normal and isoproterenol-induced myocardial infarcted rats [85] pharmacokinetics and skin concentrations of lincomycin after intravenous and oral administration to cats [86] determination of 20(s)-protopanaxadiol in human plasma by hplc–ms/ms: application to a pharmacokinetic study [87] vancomycin treatment: analysis of efficacy and safety [88] functional characterisation of human cyp2c9 allelic variants in cos-7 cells [89] misoprostol: an old drug, new indications. [90] immunogenicity of anti-tnf-α biotherapies.ii. clinical relevance of methods used for anti-drug antibody detection [91] simultaneous analysis of iridoid glycosides and anthraquinones in morinda officinalis using uplc-qqq-ms/ms and uplc-q/tof-mse [92] hplc–ms and hplc–ms/ms analysis of seven active constituents of xiao-xu-ming decoction and application to a pharmacokinetic study after oral administration to rat [93] quantification of neomangiferin in rat plasma by liquid chromatography–tandem mass spectrometry and its application to bioavailability study [94] determination of repaglinide in human plasma by high-performance liquid chromatography–tandem mass spectrometry [95] determination of 6258-70, a new semi-synthetic taxane, in rat plasma and tissues: application to the pharmacokinetics and tissue distribution study [96] maximum entropy in drug discovery [97] pharmacokinetic and bioequivalence study of a telmisartan/s-amlodipine fixed-dose combination (ckd-828) formulation and coadministered telmisartan and s-amlodipine in healthy subjects [98] preparation and evaluation of a phospholipid-based injectable gel for the long term delivery of leuprolide acetaterrh [99] the association of retinopathy and plasma glucose and hba1c: a validation of diabetes diagnostic criteria in a chinese population [100] pharmacokinetics of nuciferine and n-nornuciferine, two major alkaloids from nelumbo nucifera leaves, in rat plasma and the brain [101] Potential Implications of Hyperoside on Oxidative Stress-Induced Human Diseases: A Comprehensive Review.